Ambient air pollution exposure linked to long COVID among young adults: a nested survey in a population-based cohort in Sweden.
Air pollution
Long COVID
PM2.5
Young adults
Journal
The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
28
12
2022
revised:
17
02
2023
accepted:
17
02
2023
medline:
3
5
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
Post COVID-19 conditions, also known as long COVID, are of public health concern, but little is known about their underlying risk factors. We aimed to investigate associations of air pollution exposure with long COVID among Swedish young adults. We used data from the BAMSE (Children, Allergy, Environment, Stockholm, Epidemiology [in Swedish]) cohort. From October 2021 to February 2022 participants answered a web-questionnaire focusing on persistent symptoms following acute SARS-CoV-2 infection. Long COVID was defined as symptoms after confirmed infection with SARS-CoV-2 lasting for two months or longer. Ambient air pollution levels (particulate matter ≤2.5 μm [PM A total of 753 participants with SARS-CoV-2 infection were included of whom 116 (15.4%) reported having long COVID. The most common symptoms were altered smell/taste (n = 80, 10.6%), dyspnea (n = 36, 4.8%) and fatigue (n = 34, 4.5%). Median annual PM Ambient long-term PM The study received funding from the Swedish Research Council (grant no. 2020-01886, 2022-06340), the Swedish Research Council for Health, Working life and Welfare (FORTE grant no. 2017-01146), the Swedish Heart-Lung Foundation, Karolinska Institute (no. 2022-01807) and Region Stockholm (ALF project for cohort and database maintenance).
Sections du résumé
Background
UNASSIGNED
Post COVID-19 conditions, also known as long COVID, are of public health concern, but little is known about their underlying risk factors. We aimed to investigate associations of air pollution exposure with long COVID among Swedish young adults.
Methods
UNASSIGNED
We used data from the BAMSE (Children, Allergy, Environment, Stockholm, Epidemiology [in Swedish]) cohort. From October 2021 to February 2022 participants answered a web-questionnaire focusing on persistent symptoms following acute SARS-CoV-2 infection. Long COVID was defined as symptoms after confirmed infection with SARS-CoV-2 lasting for two months or longer. Ambient air pollution levels (particulate matter ≤2.5 μm [PM
Findings
UNASSIGNED
A total of 753 participants with SARS-CoV-2 infection were included of whom 116 (15.4%) reported having long COVID. The most common symptoms were altered smell/taste (n = 80, 10.6%), dyspnea (n = 36, 4.8%) and fatigue (n = 34, 4.5%). Median annual PM
Interpretation
UNASSIGNED
Ambient long-term PM
Funding
UNASSIGNED
The study received funding from the Swedish Research Council (grant no. 2020-01886, 2022-06340), the Swedish Research Council for Health, Working life and Welfare (FORTE grant no. 2017-01146), the Swedish Heart-Lung Foundation, Karolinska Institute (no. 2022-01807) and Region Stockholm (ALF project for cohort and database maintenance).
Identifiants
pubmed: 37131862
doi: 10.1016/j.lanepe.2023.100608
pii: S2666-7762(23)00026-1
pmc: PMC9989696
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100608Investigateurs
Catarina Almqvist
(C)
Niklas Andersson
(N)
Natalia Ballardini
(N)
Anna Bergström
(A)
Sophia Björkander
(S)
Petter Brodin
(P)
Anna Castel
(A)
Sandra Ekström
(S)
Antonios Georgelis
(A)
Lennart Hammarström
(L)
Qiang Pan-Hammarström
(Q)
Jenny Hallberg
(J)
Christer Jansson
(C)
Maura Kere
(M)
Inger Kull
(I)
André Lauber
(A)
Alexandra Lövquist
(A)
Erik Melén
(E)
Jenny Mjösberg
(J)
Ida Mogensen
(I)
Lena Palmberg
(L)
Göran Pershagen
(G)
Niclas Roxhed
(N)
Jochen Schwenk
(J)
Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors have nothing to disclose.
Références
J Infect. 2022 Feb;84(2):158-170
pubmed: 34813820
Free Radic Biol Med. 2020 May 1;151:56-68
pubmed: 32007522
Eur Respir J. 2022 Jul 26;:
pubmed: 35896215
Environ Res. 2021 Mar;194:110692
pubmed: 33385384
J Allergy Clin Immunol Pract. 2022 Jan;10(1):108-115
pubmed: 34785389
Sci Total Environ. 2020 Nov 1;741:140396
pubmed: 32592974
JAMA Psychiatry. 2022 Nov 1;79(11):1081-1091
pubmed: 36069885
JAMA Netw Open. 2022 Apr 1;5(4):e228109
pubmed: 35442452
Scand J Public Health. 2022 Feb;50(1):85-93
pubmed: 34148461
Atmos Pollut Res. 2021 Jan;12(1):437-445
pubmed: 33046960
Eur Respir Rev. 2022 Aug 10;31(165):
pubmed: 35948392
Lancet Reg Health Eur. 2021 Jul;6:100122
pubmed: 34027514
JAMA. 2022 Oct 25;328(16):1604-1615
pubmed: 36215063
Nat Med. 2022 Aug;28(8):1706-1714
pubmed: 35879616
Environ Health Perspect. 2022 Feb;130(2):27005
pubmed: 35139319
J Allergy Clin Immunol. 2012 Jan;129(1):240-6
pubmed: 22104609
Environ Res. 2022 Dec;215(Pt 2):114364
pubmed: 36126692
Euro Surveill. 2006;11(5):103-7
pubmed: 16757847
J Infect Dis. 2022 Jan 18;225(2):214-218
pubmed: 34734257
Lancet. 2022 Aug 6;400(10350):452-461
pubmed: 35934007
Sci Total Environ. 2020 Aug 10;729:138474
pubmed: 32498152
Sci Adv. 2020 Nov 4;6(45):
pubmed: 33148655
Curr Allergy Asthma Rep. 2017 Jun;17(6):41
pubmed: 28551888
Environ Health Perspect. 2017 Jun 16;125(6):067007
pubmed: 28669936
Environ Res. 2020 Aug;187:109652
pubmed: 32405084
Am J Respir Crit Care Med. 2023 Feb 15;207(4):406-415
pubmed: 36409973
Environ Pollut. 2022 Jan 1;292(Pt A):118336
pubmed: 34634403
Environ Int. 2021 Sep;154:106564
pubmed: 33964723
J Glob Health. 2022 Aug 09;12:05029
pubmed: 35939273
Lancet Respir Med. 2022 Sep;10(9):863-876
pubmed: 35568052
J Allergy Clin Immunol. 2022 Jan;149(1):65-75.e8
pubmed: 34695490
CMAJ. 2022 May 24;194(20):E693-E700
pubmed: 35609912
Pediatr Infect Dis J. 2020 May;39(5):355-368
pubmed: 32310621
Environ Sci Pollut Res Int. 2019 Jul;26(19):19697-19704
pubmed: 31079306
Clin Transl Allergy. 2020 May 25;10:15
pubmed: 32489587
Sci Total Environ. 2022 Apr 10;816:151654
pubmed: 34785217
Am J Respir Crit Care Med. 2022 Aug 15;206(4):440-448
pubmed: 35537137
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Lancet Respir Med. 2014 Feb;2(2):131-40
pubmed: 24503268
Am J Respir Crit Care Med. 2022 Mar 15;205(6):651-662
pubmed: 34881681
Environ Health Perspect. 2021 Nov;129(11):117003
pubmed: 34787480
Chemosphere. 2021 Jan;263:128297
pubmed: 33297239
Int J Environ Res Public Health. 2017 Jul 07;14(7):
pubmed: 28686215
Clin Rheumatol. 2020 Mar;39(3):761-768
pubmed: 31729679
Eur Respir J. 2017 Jan 11;49(1):
pubmed: 28077473
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238